title: COX-2 targeting in cancer: a new beginning?
authors.forename: M
authors.initials: M
authors.lastname: Milella
authors.forename: G
authors.initials: G
authors.lastname: Metro
authors.forename: A
authors.initials: A
authors.lastname: Gelibter
authors.forename: S M
authors.initials: SM
authors.lastname: Pino
authors.forename: F
authors.initials: F
authors.lastname: Cognetti
authors.forename: A
authors.initials: A
authors.lastname: Fabi
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D051546:Cyclooxygenase 2 / Q000096:biosynthesis*; D052246:Cyclooxygenase 2 Inhibitors / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D052246:Cyclooxygenase 2 Inhibitors; D051546:Cyclooxygenase 2